Cecswiki at 17:25, 4 November 2020

2020-11-04T17:25:33Z

← Older revision		Revision as of 17:25, 4 November 2020
Line 7:		Line 7:
	{\| class="wikitable sortable" border="1" style="border-collapse: collapse;" cellpadding="2"		{\| class="wikitable sortable" border="1" style="border-collapse: collapse;" cellpadding="2"
	\|-		\|-
	!width="~~450pt~~" \| Vaccine		!width="400pt" \| Vaccine
	!width="100pt" \| NDC #		!width="100pt" \| NDC #
	!style="text-align: center;" width="100pt" \| CVX Code		!style="text-align: center;" width="100pt" \| CVX Code

Cecswiki at 17:25, 4 November 2020

2020-11-04T17:25:17Z

Show changes

Cecswiki at 16:09, 4 November 2020

2020-11-04T16:09:56Z

← Older revision		Revision as of 16:09, 4 November 2020
Line 2:		Line 2:
	Certain States require this code to be sent in place of or in addition		Certain States require this code to be sent in place of or in addition
	to the NDC number for the vaccine.		to the NDC number for the vaccine.

			'''Note''': Use Control + F on your keyboard to find keywords or NDC #'s.

	{\| class="wikitable sortable" border="1" style="border-collapse: collapse;" cellpadding="2"		{\| class="wikitable sortable" border="1" style="border-collapse: collapse;" cellpadding="2"
	\|-		\|-

Cecswiki: Created page with "==CVX Codes for Vaccines== Certain States require this code to be sent in place of or in addition to the NDC number for the vaccine. {| class="wikitable sortable" border="1" s..."

2020-11-03T19:54:44Z

Created page with "==CVX Codes for Vaccines== Certain States require this code to be sent in place of or in addition to the NDC number for the vaccine. {| class="wikitable sortable" border="1" s..."

New page

==CVX Codes for Vaccines==
Certain States require this code to be sent in place of or in addition
to the NDC number for the vaccine.
{| class="wikitable sortable" border="1" style="border-collapse: collapse;" cellpadding="2"
|-
!width="450pt" | Vaccine
!width="100pt" | NDC #
!style="text-align: center;" width="100pt" | CVX Code
|-
| Hib (PRP-T) || 49281-0547-58 || style="text-align: center;" | 48
|-
| Tdap || 49281-0400-89 || style="text-align: center;" | 115
|-
| Tdap || 49281-0400-58 || style="text-align: center;" | 115
|-
| Tdap || 49281-0400-88 || style="text-align: center;" | 115
|-
| Adenovirus types 4 and 7 || 51285-0175-02 || style="text-align: center;" | 143
|-
| Adenovirus types 4 and 7 || 51285-0174-02 || style="text-align: center;" | 143
|-
| Influenza, injectable,quadrivalent, preservative free, pediatric || 33332-0220-21 || style="text-align: center;" | 161
|-
| influenza, injectable, quadrivalent || 33332-0420-11 || style="text-align: center;" | 158
|-
| influenza, injectable, quadrivalent, preservative free || 33332-0320-02 || style="text-align: center;" | 150
|-
| BCG || 00052-0603-01 || style="text-align: center;" | 19
|-
| meningococcal B, OMV || 58160-0976-02 || style="text-align: center;" | 163
|-
| anthrax || 64678-0211-05 || style="text-align: center;" | 24
|-
| Tdap || 58160-0842-05 || style="text-align: center;" | 115
|-
| Tdap || 58160-0842-43 || style="text-align: center;" | 115
|-
| Tdap || 58160-0842-01 || style="text-align: center;" | 115
|-
| DTaP, 5 pertussis antigens || 49281-0286-58 || style="text-align: center;" | 106
|-
| dengue fever || 49281-0606-58 || style="text-align: center;" | 56
|-
| DT (pediatric) || 49281-0225-58 || style="text-align: center;" | 28
|-
| Hep B, adult || 58160-0821-01 || style="text-align: center;" | 43
|-
| Hep B, adult || 58160-0821-43 || style="text-align: center;" | 43
|-
| Hep B, adolescent or pediatric || 58160-0820-43 || style="text-align: center;" | 08
|-
| Hep B, adult || 58160-0821-05 || style="text-align: center;" | 43
|-
| influenza, trivalent, adjuvanted || 70461-0020-04 || style="text-align: center;" | 168
|-
| Influenza vaccine, quadrivalent, adjuvanted || 70461-0120-04 || style="text-align: center;" | 205
|-
| influenza, injectable, quadrivalent, preservative free || 58160-0885-41 || style="text-align: center;" | 150
|-
| influenza, recombinant, quadrivalent,injectable, preservative free || 49281-0720-88 || style="text-align: center;" | 185
|-
| Influenza, injectable, MDCK, quadrivalent, preservative || 70461-0420-11 || style="text-align: center;" | 186
|-
| Influenza, injectable, MDCK, preservative free, quadrivalent || 70461-0320-04 || style="text-align: center;" | 171
|-
| influenza, injectable, quadrivalent, preservative free || 19515-0816-41 || style="text-align: center;" | 150
|-
| influenza, live, intranasal, quadrivalent || 66019-0307-01 || style="text-align: center;" | 149
|-
| influenza, high-dose, quadrivalent || 49281-0120-88 || style="text-align: center;" | 197
|-
| influenza, injectable, quadrivalent, preservative free || 49281-0420-88 || style="text-align: center;" | 150
|-
| influenza, injectable, quadrivalent, preservative free || 49281-0420-58 || style="text-align: center;" | 150
|-
| Influenza, injectable,quadrivalent, preservative free, pediatric || 49281-0520-00 || style="text-align: center;" | 161
|-
| influenza, injectable, quadrivalent || 49281-0633-78 || style="text-align: center;" | 158
|-
| influenza, Southern Hemisphere, quadrivalent, with preservative || 49281-0336-78 || style="text-align: center;" | 202
|-
| influenza, Southern Hemisphere, preservative free || 49281-0320-88 || style="text-align: center;" | 201
|-
| influenza, Southern Hemisphere, pediatric, preservative free || 49281-0181-00 || style="text-align: center;" | 200
|-
| HPV, quadrivalent || 00006-4045-01 || style="text-align: center;" | 62
|-
| HPV, quadrivalent || 00006-4109-01 || style="text-align: center;" | 62
|-
| HPV9 || 00006-4121-01 || style="text-align: center;" | 165
|-
| HPV9 || 00006-4119-01 || style="text-align: center;" | 165
|-
| Hep A, ped/adol, 2 dose || 58160-0825-43 || style="text-align: center;" | 83
|-
| Hep A, adult || 58160-0826-01 || style="text-align: center;" | 52
|-
| Hep A, adult || 58160-0826-43 || style="text-align: center;" | 52
|-
| Hep A, ped/adol, 2 dose || 58160-0825-01 || style="text-align: center;" | 83
|-
| HepB-CpG || 43528-0003-01 || style="text-align: center;" | 189
|-
| Hib (PRP-T) || 58160-0816-05 || style="text-align: center;" | 48
|-
| Hib (PRP-T) || 58160-0816-01 || style="text-align: center;" | 48
|-
| Rabies - IM Diploid cell culture || 49281-0246-58 || style="text-align: center;" | 175
|-
| Rabies - IM Diploid cell culture || 49281-0248-58 || style="text-align: center;" | 175
|-
| DTaP || 58160-0810-01 || style="text-align: center;" | 20
|-
| DTaP || 50090-2883-09 || style="text-align: center;" | 20
|-
| DTaP || 58160-0810-43 || style="text-align: center;" | 20
|-
| Influenza A monovalent (H5N1), ADJUVANTED-2013 || 58160-0804-01 || style="text-align: center;" | 160
|-
| Influenza A monovalent (H5N1), ADJUVANTED-2013 || 58160-0802-02 || style="text-align: center;" | 160
|-
| IPV || 49281-0860-78 || style="text-align: center;" | 10
|-
| Japanese Encephalitis IM || 62195-0051-01 || style="text-align: center;" | 134
|-
| Japanese Encephalitis IM || 42515-0001-00 || style="text-align: center;" | 134
|-
| Japanese Encephalitis IM || 42515-0002-01 || style="text-align: center;" | 134
|-
| DTaP-IPV || 58160-0812-43 || style="text-align: center;" | 130
|-
| DTaP-IPV || 58160-0812-01 || style="text-align: center;" | 130
|-
| meningococcal MCV4P || 49281-0589-58 || style="text-align: center;" | 114
|-
| meningococcal polysaccharide (groups A, C, Y, W-135) TT conjugate || 49281-0590-58 || style="text-align: center;" | 203
|-
| Meningococcal MCV4O || 58160-0958-01 || style="text-align: center;" | 136
|-
| Meningococcal MCV4O || 58160-0959-01 || style="text-align: center;" | 136
|-
| MMR || 00006-4681-01 || style="text-align: center;" | 03
|-
| DTaP-Hep B-IPV || 58160-0811-43 || style="text-align: center;" | 110
|-
| Hib (PRP-OMP) || 00006-4897-01 || style="text-align: center;" | 49
|-
| DTaP-Hib-IPV || 49281-0560-05 || style="text-align: center;" | 120
|-
| DTaP-Hib-IPV || 49281-0561-01 || style="text-align: center;" | 120
|-
| DTaP-Hib-IPV || 49281-0548-58 || style="text-align: center;" | 120
|-
| DTaP-Hib-IPV || 49281-0544-58 || style="text-align: center;" | 120
|-
| pneumococcal polysaccharide PPV23 || 00006-4943-01 || style="text-align: center;" | 33
|-
| pneumococcal polysaccharide PPV23 || 00006-4837-01 || style="text-align: center;" | 33
|-
| Pneumococcal conjugate PCV 13 || 00005-1971-01 || style="text-align: center;" | 133
|-
| MMRV || 00006-4171-01 || style="text-align: center;" | 94
|-
| DTaP-IPV || 49281-0562-58 || style="text-align: center;" | 130
|-
| Rabies - IM fibroblast culture || 58160-0966-01 || style="text-align: center;" | 176
|-
| Hep B, dialysis || 00006-4992-01 || style="text-align: center;" | 44
|-
| Hep B, adolescent or pediatric || 00006-4093-01 || style="text-align: center;" | 08
|-
| Hep B, adult || 00006-4094-01 || style="text-align: center;" | 43
|-
| Hep B, adult || 00006-4995-01 || style="text-align: center;" | 43
|-
| Hep B, adolescent or pediatric || 00006-4981-01 || style="text-align: center;" | 08
|-
| rotavirus, monovalent || 58160-0851-01 || style="text-align: center;" | 119
|-
| rotavirus, pentavalent || 00006-4047-01 || style="text-align: center;" | 116
|-
| zoster recombinant || 58160-0828-01 || style="text-align: center;" | 187
|-
| zoster recombinant || 58160-0828-03 || style="text-align: center;" | 187
|-
| Yellow fever vaccine - alt || 49281-0913-01 || style="text-align: center;" | 183
|-
| Td (adult), 2 Lf tetanus toxoid, preservative free, adsorbed || 14362-0111-03 || style="text-align: center;" | 09
|-
| Td (adult), 2 Lf tetanus toxoid, preservative free, adsorbed || 13533-0131-00 || style="text-align: center;" | 09
|-
| Td (adult), 5 Lf tetanus toxoid, preservative free, adsorbed || 49281-0215-58 || style="text-align: center;" | 113
|-
| Td (adult), 5 Lf tetanus toxoid, preservative free, adsorbed || 49281-0215-88 || style="text-align: center;" | 113
|-
| meningococcal B, recombinant || 00005-0100-01 || style="text-align: center;" | 162
|-
| Hep A-Hep B || 58160-0815-43 || style="text-align: center;" | 104
|-
| Hep A-Hep B || 58160-0815-41 || style="text-align: center;" | 104
|-
| typhoid, ViCPs || 49281-0790-88 || style="text-align: center;" | 101
|-
| typhoid, ViCPs || 49281-0790-38 || style="text-align: center;" | 101
|-
| Hep A, adult || 00006-4841-01 || style="text-align: center;" | 52
|-
| Hep A, ped/adol, 2 dose || 00006-4095-01 || style="text-align: center;" | 83
|-
| Hep A, ped/adol, 2 dose || 00006-4831-01 || style="text-align: center;" | 83
|-
| Hep A, adult || 00006-4096-01 || style="text-align: center;" | 52
|-
| varicella || 00006-4826-01 || style="text-align: center;" | 21
|-
| varicella || 00006-4827-01 || style="text-align: center;" | 21
|-
| cholera, live attenuated || 70460-0002-02 || style="text-align: center;" | 174
|-
| DTaP,IPV,Hib,HepB || 63361-0243-58 || style="text-align: center;" | 146
|-
| typhoid, oral || 69401-0000-01 || style="text-align: center;" | 25
|-
| typhoid, oral || 69401-0000-01 || style="text-align: center;" | 25
|-
| yellow fever || 49281-0915-58 || style="text-align: center;" | 37
|-
| yellow fever || 49281-0915-68 || style="text-align: center;" | 37
|-
| zoster live || 00006-4963-01 || style="text-align: center;" | 121
|}

CvxCodes - Revision history

Cecswiki at 17:25, 4 November 2020

Cecswiki at 17:25, 4 November 2020

Cecswiki at 16:09, 4 November 2020

Cecswiki: Created page with "==CVX Codes for Vaccines== Certain States require this code to be sent in place of or in addition to the NDC number for the vaccine. {| class="wikitable sortable" border="1" s..."